List With HCPCS Codes For Screening

The HCPCS codes for Screening (G9919-G9932) are used to describe various screening procedures and outcomes, as well as the provision of recommendations and documentation related to safety concerns, anticoagulant prescriptions, and risk assessment for certain medical conditions.

1. HCPCS Code G9919

HCPCS G9919 describes the performance of a screening test that yields a positive result, along with the provision of recommendations based on the findings.

2. HCPCS Code G9920

HCPCS G9920 indicates that a screening test was performed and the result was negative.

3. HCPCS Code G9921

HCPCS G9921 is used when no screening test was performed, only a partial screening was conducted, or a positive screening result was obtained without any given reason or specification.

4. HCPCS Code G9922

HCPCS G9922 is used when a safety concerns screening is provided, and if the result is positive, documented mitigation recommendations are provided.

5. HCPCS Code G9923

HCPCS G9923 indicates that a safety concerns screening was provided and the result was negative.

6. HCPCS Code G9925

HCPCS G9925 is used when safety concerns screening was not provided, and the reason for not providing it is not otherwise specified.

7. HCPCS Code G9926

HCPCS G9926 is used when a safety concerns screening yields a positive result without the provision of mitigation recommendations, including referrals to other resources.

8. HCPCS Code G9928

HCPCS G9928 indicates that an FDA-approved anticoagulant was not prescribed, and the reason for not prescribing it is not given.

9. HCPCS Code G9929

HCPCS G9929 is used for patients with transient or reversible causes of atrial fibrillation (AF), such as pneumonia, hyperthyroidism, pregnancy, or cardiac surgery.

10. HCPCS Code G9930

HCPCS G9930 is used for patients who are receiving comfort care only, indicating that screening or treatment interventions may not be appropriate.

11. HCPCS Code G9931

HCPCS G9931 is used to document the CHA2DS2-VASc risk score of 0 or 1 for men, or 0, 1, or 2 for women, which helps assess the risk of stroke in patients with atrial fibrillation.